Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-10

Clinical Trial Update: Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the dose-response effects of inhaled fluticasone on airway responses to hypertonic saline in individuals with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluticasone propionate (Fluticasone propionate)

Snippet

Sponsor: University of California, San Francisco | Conditions: Asthma | Phase 4 | Status: COMPLETED